Director/PDMR Shareholding

RNS Number : 2836I

Hikma Pharmaceuticals Plc

10 December 2020

 

Hikma Pharmaceuticals PLC

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Said Darwazah
2	Reason for the notification
a)	Position/status	Executive Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083
b)	Nature of the transaction	Pledge by Darhold Limited of 1,500,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of J.P. Morgan (Suisse) SA.  Darhold Limited is defined as a Person Closely Associated with the Executive Chairman, who is a director of and shareholder in Darhold Limited
c)	Price(s) and volume(s)	Price(s): £0.00p Volume(s): 1,500,000
d)	Aggregated information	Aggregated volume: 1,500,000 Price: £0.00p
e)	Date of the transaction	10 December 2020
f)	Place of the transaction	Amman

 Mazen Darwazah

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mazen Darwazah
2	Reason for the notification
a)	Position/status	Executive Vice Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083
b)	Nature of the transaction	Pledge by Darhold Limited of 1,500,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of J.P. Morgan (Suisse) SA.  Darhold Limited is defined as a Person Closely Associated with the Executive Vice Chairman, who is a director of and shareholder in Darhold Limited.
c)	Price(s) and volume(s)	Price(s): £0.00p Volume(s): 1,500,000
d)	Aggregated information	Aggregated volume: 1,500,000 Price: £0.00p
e)	Date of the transaction	10 December 2020
f)	Place of the transaction	Amman

Mohammed 'Ali' Al-Husry

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mohammed 'Ali' Al-Husry
2	Reason for the notification
a)	Position/status	Non-Executive Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083
b)	Nature of the transaction	Pledge by Darhold Limited of 1,500,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of J.P. Morgan (Suisse) SA.  Darhold Limited is defined as a Person Closely Associated with the the Non-Executive Director, who is a director of and shareholder in Darhold Limited.
c)	Price(s) and volume(s)	Price(s): £0.00p Volume(s): 1,500,000
d)	Aggregated information	Aggregated volume: 1,500,000 Price: £0.00p
e)	Date of the transaction	10 December 2020
f)	Place of the transaction	Amman

Peter Speirs
Company Secretary, responsible for releasing this announcement
[phone]

 

END

 

 

DSHBUBDDCUBDGGG